Tisdag 26 November | 05:22:05 Europe / Stockholm
Svenska | English

Bio-Works Technologies

Bifogade filer

Kursutveckling under dagen för detta pressmeddelande (SEK).

Likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

Tid*
2025-02-21 08:30 Bokslutskommuniké 2024
2024-08-02 - Kvartalsrapport 2024-Q2
2024-07-29 - Extra Bolagsstämma 2024
2024-05-27 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2024-05-24 - Årsstämma
2024-02-19 - Bokslutskommuniké 2023
2023-08-18 - Kvartalsrapport 2023-Q2
2023-05-29 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-08-19 - Kvartalsrapport 2022-Q2
2022-05-23 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2022-05-20 - Årsstämma
2022-05-06 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2022-02-18 - Bokslutskommuniké 2021
2021-11-25 - Extra Bolagsstämma 2021
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-24 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2021-05-21 - Årsstämma
2021-02-19 - Bokslutskommuniké 2020
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-18 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2020-05-15 - Årsstämma
2020-02-14 - Bokslutskommuniké 2019
2019-10-18 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-05-27 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2019-05-17 - Årsstämma
2019-04-29 - Kvartalsrapport 2019-Q1
2019-02-22 - Bokslutskommuniké 2018
2018-08-19 - Kvartalsrapport 2018-Q2
2018-05-21 - X-dag ordinarie utdelning BIOWKS 0.00 SEK
2018-05-18 - Årsstämma
2018-02-19 - Bokslutskommuniké 2017

Beskrivning

LandSverige
ListaSpotlight
SektorHälsovård
IndustriBioteknik
Bio-Works Technologies är verksamt inom bioteknik. Bolaget utvecklar produkter som separerar och renar molekyler vid framställning av läkemedel. Teknologin baseras på kromatografi som har som avsikt att hantera läkemedelssubstansen. Kunderna återfinns inom den europeiska marknaden där produkterna säljs via distributionspartners och till bolag inom läkemedelsindustrin, samt forskningsinstitut och universitet. Bolaget bildades 2006 och har sitt huvudkontor i Uppsala.
Bio-Works expands product range with introduction of WorkBeads 40 Butyl SH
2024-02-16 08:45:00

WorkBeads 40 Butyl SH is a pioneering hydrophobic interaction chromatography (HIC) resin for purification of plasmids, proteins, peptides, and oligonucleotides

Today, Bio-Works, a trailblazer in purification solutions, is thrilled to announce the addition of WorkBeads™ 40 Butyl SH to its product portfolio. This revolutionary hydrophobic interaction chromatography (HIC) resin is designed for research and industrial-scale purification of proteins, peptides, plasmids, and oligonucleotides. This launch marks a significant expansion of Bio-Works' product range.

Advantages of WorkBeads 40 Butyl SH include:

  • High Throughput and Purity: WorkBeads 40 Butyl SH offers high binding capacity and purity, enhancing the efficiency of the purification process.
  • Chemical Stability: The resin's high chemical stability allows for easy cleaning-in-place, ensuring reproducible and reliable results.
  • Convenience and Reproducibility: The prepacked GoBio columns provide convenience and reproducibility in purification workflows, saving valuable time and resources.

Jonathan Royce, CEO at Bio-Works, emphasized the strategic importance of widening the product range, stating, "The addition of WorkBeads 40 Butyl SH is a testament to our commitment to offering comprehensive solutions for protein purification. It enhances our ability to meet the diversifying needs of our customers."

WorkBeads 40 Butyl SH, featuring a n-butyl thioether ligand, provides minimal mixed-mode interactions, ensuring reliable binding performance. The resin is also available in various ready-to-use prepacked column sizes, GoBio™ Mini, GoBio Screen, GoBio Prep, and GoBio Prod. These columns cater to diverse purification needs, from small-scale research applications to large-scale production.

For more information about WorkBeads 40 Butyl SH, its applications, and the expanded product range, please visit www.bio-works.com/product/hic-resin. Orders can be conveniently placed through the website.

Contacts
For more information, please visit the Bio-Works homepage at, www.bio-works.com or contact: Jonathan Royce, CEO, e-mail: jonathan.royce@bio-works.com, phone: +46(0)8-502 705 82.

About Bio-Works
Bio-Works enables scientists to achieve their purification goals, from laboratory research to large scale bioprocess production. Our vision is a biotech industry that embraces, develops and builds on new methods and novel ideas. WorkBeads™, Bio-Works’ next-generation, agarose-based products, are used to purify proteins, peptides and other biomolecules, resulting in purer therapies and safer diagnostics. Through collaboration with customers and partners, we develop purification solutions that make important medicines available and accessible to everyone.

Bio-Works’ headquarters, with R&D and manufacturing, is located in Uppsala Business Park in Uppsala, Sweden. We supply products globally, through a combination of direct sales and via distributors in Europe, North America and Asia. The company is certified according to the ISO 9001:2015 quality management system. Bio-Works is listed on Nasdaq First North (“BIOWKS”), and FNCA Sweden AB is appointed Certified Adviser. For more information, visit www.bio-works.com.

Image Attachments
WorkBeads 40 Butyl SH product group

Attachments
Bio-Works expands product range with introduction of WorkBeads 40 Butyl SH

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden